SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-017788
Filing Date
2021-03-25
Accepted
2021-03-25 17:14:12
Documents
4
Period of Report
2021-03-25
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea138362-8k_pluristem.htm 8-K 24417
2 LETTER FROM KOST, FORER, GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, AD ea138362ex16-1_pluristem.htm EX-16.1 4832
3 GRAPHIC image_004.jpg GRAPHIC 2886
4 GRAPHIC image_005.jpg GRAPHIC 3690
  Complete submission text file 0001213900-21-017788.txt   39965
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 21773510
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences